Skip to content

Evaluation 2% Chlorhexidine Gluconate

Evaluation of the Area Covered by Medline 2% Chlorhexidine Gluconate Cloth Preoperative Skin Preparation

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03326726
Enrollment
30
Registered
2017-10-31
Start date
2016-11-16
Completion date
2016-11-18
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Coverage

Brief summary

Medline 2% CHG cloth (Active) - A single cloth from the pack was used per treatment area. The investigational test article was applied topically by vigorously scrubbing the skin in a back and forth motion for three minutes (and halfway through the 3-minute application time, the cloth was turned over) over the treatment area (7 x 10 of the subject's back), and the skin was allowed to air dry.

Interventions

DRUG2% CHG

Chlorhexidine Gluconate

Sponsors

Medline Industries
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy males of at least 18 years of age having skin within 6 inches of the test regions that were free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders, with no history of sensitivity to CHG and were able to lie prone for up to 30 minutes.

Design outcomes

Primary

MeasureTime frameDescription
Medline 2% CHG Cloth Dosage of Coverage Area3 minutesTo measure the dosage of the coverage area of a single investigational test article, Medline 2% CHG cloth calculated in grams per square centimeter

Secondary

MeasureTime frameDescription
Post-application Drying TimeApproximately 1 minuteTo assess post-application drying time after a single dose topical application of Medline 2% CHG cloth. Drying time is defined as when the entire treatment area appears visibly dry.

Participant flow

Recruitment details

Healthy males at least 18 years of age having skin within 6 inches of the test regions that were free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders, with no histroy of sensitivity to CHG and able to lie prone for up to 30 minutes.

Participants by arm

ArmCount
2% CHG Cloth
2% chlorhexidine gluconate cloth
30
Total30

Baseline characteristics

Characteristic2% CHG Cloth
Age, Continuous34 years
STANDARD_DEVIATION 15
Race/Ethnicity, Customized
Race/Ethniticy
Asian
11 Participants
Race/Ethnicity, Customized
Race/Ethniticy
Black or African American
7 Participants
Race/Ethnicity, Customized
Race/Ethniticy
Hispanic or Latino
2 Participants
Race/Ethnicity, Customized
Race/Ethniticy
Other
3 Participants
Race/Ethnicity, Customized
Race/Ethniticy
White
7 Participants
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Medline 2% CHG Cloth Dosage of Coverage Area

To measure the dosage of the coverage area of a single investigational test article, Medline 2% CHG cloth calculated in grams per square centimeter

Time frame: 3 minutes

ArmMeasureValue (MEAN)Dispersion
2% CHG ClothMedline 2% CHG Cloth Dosage of Coverage Area0.0081 g/cm^2Standard Deviation 0.0013
Secondary

Post-application Drying Time

To assess post-application drying time after a single dose topical application of Medline 2% CHG cloth. Drying time is defined as when the entire treatment area appears visibly dry.

Time frame: Approximately 1 minute

ArmMeasureValue (MEAN)Dispersion
2% CHG ClothPost-application Drying Time70 secondsStandard Deviation 18

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026